-- Pfizer, Protalix Submit Experimental Gaucher Disease Medicine in Europe
-- B y   A n g e l a   C u l l e n
-- 2010-11-29T07:04:01Z
-- http://www.bloomberg.com/news/2010-11-29/pfizer-protalix-submit-gaucher-disease-drug-in-europe.html
Pfizer Inc. and Protalix
BioTherapeutics Inc. submitted the experimental taliglucerase
alfa medicine designed to treat Gaucher disease for review in
Europe.  To contact the editor responsible for this story:
Angela Cullen at 
 acullen8@bloomberg.net  